Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab vs Cisplatin with Radiotherapy in LA-HNSCC
NCT01216020Phase 2Terminated
- Sponsor
- Azienda USL 4 Prato
- Start
- Oct 2010
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in head and neck squamous cell carcinoma (HNSCC), sponsored by Azienda USL 4 Prato. Started Oct 2010; status: terminated.
02
Drugs
KL-140
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01216020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216020.